CorMedix IncNASDAQ:CRMD
- LAST PRICE9.8650
- TODAY'S CHANGE (%)-0.1150 (-1.1523%)
- Bid / Lots9.8500/ 1
- Ask / Lots10.0500/ 10
- Open / Previous Close9.9800 / 9.9800
- Day Range
- 52 Week Range
- Volume323,397
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 21421 | 10.105 |
| 09:33 ET | 3520 | 10.08 |
| 09:37 ET | 200 | 10.05 |
| 09:39 ET | 200 | 10.055 |
| 09:42 ET | 6502 | 9.99 |
| 09:44 ET | 1200 | 9.985 |
| 09:46 ET | 452 | 9.985 |
| 09:48 ET | 18378 | 9.85 |
| 09:50 ET | 1191 | 9.89 |
| 09:51 ET | 100 | 9.87 |
| 09:53 ET | 800 | 9.8606 |
| 09:57 ET | 100 | 9.855 |
| 10:00 ET | 200 | 9.88 |
| 10:02 ET | 1163 | 9.87 |
| 10:04 ET | 5866 | 9.78 |
| 10:06 ET | 3000 | 9.79 |
| 10:08 ET | 3178 | 9.8 |
| 10:09 ET | 490 | 9.8172 |
| 10:11 ET | 709 | 9.82 |
| 10:13 ET | 385 | 9.86 |
| 10:15 ET | 350 | 9.89 |
| 10:18 ET | 1400 | 9.86 |
| 10:20 ET | 100 | 9.885 |
| 10:22 ET | 800 | 9.8849 |
| 10:24 ET | 1700 | 9.895 |
| 10:26 ET | 200 | 9.88 |
| 10:27 ET | 1100 | 9.835 |
| 10:29 ET | 152 | 9.81 |
| 10:31 ET | 200 | 9.8321 |
| 10:33 ET | 848 | 9.86 |
| 10:36 ET | 100 | 9.86 |
| 10:38 ET | 100 | 9.855 |
| 10:40 ET | 130 | 9.855 |
| 10:42 ET | 2351 | 9.87 |
| 10:45 ET | 307 | 9.885 |
| 10:47 ET | 1336 | 9.885 |
| 10:49 ET | 1753 | 9.89 |
| 10:51 ET | 200 | 9.895 |
| 10:56 ET | 400 | 9.9 |
| 10:58 ET | 503 | 9.94 |
| 11:00 ET | 550 | 9.94 |
| 11:02 ET | 550 | 9.94 |
| 11:03 ET | 1006 | 9.94 |
| 11:05 ET | 300 | 9.95 |
| 11:07 ET | 433 | 9.94 |
| 11:09 ET | 1245 | 9.9048 |
| 11:12 ET | 311 | 9.925 |
| 11:14 ET | 663 | 9.885 |
| 11:16 ET | 500 | 9.8861 |
| 11:18 ET | 1802 | 9.88 |
| 11:20 ET | 1124 | 9.8366 |
| 11:23 ET | 258 | 9.85 |
| 11:25 ET | 100 | 9.87 |
| 11:27 ET | 1104 | 9.86 |
| 11:30 ET | 1775 | 9.865 |
| 11:32 ET | 300 | 9.87 |
| 11:34 ET | 100 | 9.87 |
| 11:36 ET | 813 | 9.86 |
| 11:38 ET | 200 | 9.86 |
| 11:39 ET | 200 | 9.865 |
| 11:43 ET | 1200 | 9.88 |
| 11:45 ET | 1396 | 9.88 |
| 11:48 ET | 1871 | 9.87 |
| 11:52 ET | 100 | 9.89 |
| 11:54 ET | 2390 | 9.87 |
| 11:56 ET | 379 | 9.87 |
| 11:57 ET | 100 | 9.87 |
| 11:59 ET | 100 | 9.875 |
| 12:01 ET | 2983 | 9.83 |
| 12:03 ET | 200 | 9.815 |
| 12:06 ET | 100 | 9.82 |
| 12:08 ET | 100 | 9.815 |
| 12:10 ET | 800 | 9.8134 |
| 12:12 ET | 3589 | 9.8 |
| 12:15 ET | 5657 | 9.8 |
| 12:17 ET | 925 | 9.79 |
| 12:19 ET | 200 | 9.8 |
| 12:21 ET | 1066 | 9.82 |
| 12:24 ET | 7947 | 9.81 |
| 12:26 ET | 623 | 9.805 |
| 12:28 ET | 2711 | 9.81 |
| 12:30 ET | 800 | 9.81 |
| 12:32 ET | 100 | 9.81 |
| 12:33 ET | 100 | 9.81 |
| 12:35 ET | 2100 | 9.86 |
| 12:37 ET | 1218 | 9.84 |
| 12:39 ET | 100 | 9.86 |
| 12:42 ET | 300 | 9.87 |
| 12:44 ET | 8870 | 9.93 |
| 12:46 ET | 2200 | 9.94 |
| 12:48 ET | 2309 | 9.9 |
| 12:50 ET | 2864 | 9.9 |
| 12:51 ET | 1210 | 9.88 |
| 12:53 ET | 1650 | 9.88 |
| 12:55 ET | 2546 | 9.8799 |
| 12:57 ET | 7855 | 9.88 |
| 01:00 ET | 70748 | 9.865 |
Nov 26, 2024
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products, from 8:30AM ET on Tuesday Nov 26, 2024 by Dow Jones
8:30AM ET on Tuesday Nov 26, 2024 by Dow Jones
Nov 4, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:56AM ET on Wednesday Oct 30, 2024 by Dow JonesCorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 605.6M | -12.3x | --- |
Zevra Therapeutics Inc | 503.3M | -4.8x | --- |
Elite Pharmaceuticals Inc | 627.6M | -100.0x | --- |
Eton Pharmaceuticals Inc | 329.2M | -63.4x | --- |
Cipla Ltd | 14.3B | 0.0x | --- |
Incannex Healthcare Inc | 32.1M | -1.3x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Chief Clinical Strategy and Operations Officer
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- Beth Kaufman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $605.6M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 60.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.55 |
EPS | $-0.80 |
Book Value | $1.28 |
P/E Ratio | -12.3x |
Price/Sales (TTM) | 49.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -415.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
